INmune Bio, Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, August 4

July 28, 2021

Biotechnology

Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21

May 30, 2023
ChromaDex to Participate in the LD Micro Invitational XIII

May 30, 2023
Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference

May 30, 2023
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer

May 30, 2023